Perspective Therapeutics, Inc. (CATX) Reports In-Line Q3 EPS
Tweet
Share
E-mailGet Alerts CATX Hot Sheet
Join SI Premium – FREE
Perspective Therapeutics, Inc. (NYSE: CATX) reported Q3 EPS of ($0.21), in-line with the analyst estimate of ($0.21). Revenue for the quarter came in at $369 thousand versus the consensus estimate of $191.73 thousand.
For earnings history and earnings-related data on Perspective Therapeutics, Inc. (CATX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Barclays Upgrades 1&1 AG (1U1:GR) to Overweight
- Morgan Stanley Upgrades Qualcomm (QCOM) to Equalweight
- Barclays Downgrades Brown Forman (BF-B) to Equalweight
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
